RxDoctor Payments Data

Olivia Wang, MD

Hand Surgery · Las Vegas, NVNPI 1154610137

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (36.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 41.3% of the total. Reporting peaked in 2019 at $2,482 and has fallen 92.0% since, to $198 in 2025. That places this record below the midpoint for hand surgery clinicians in NV, where the typical reported total is $6,204.

$5,273in general payments, 2019–2025

Across 46 payments — averaging $114.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Acumed LLC$2K
  • Stryker$376
  • Endo USA, Inc.$194
  • Endo Pharmaceuticals Inc.$185
  • Avita Medical Americas, LLC$109
  • plus $503 from 11 others

What the payments were for

  • Travel & lodging$1,89436%
  • Food & beverage$1,94337%
  • Education$1,43627%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,273 in reported general payments places this provider in the 45th percentile of 24 hand surgery providers in Nevada.

See all hand surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$110,387
Medicare patients
286
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin21$237
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$201
Tramadol Hcl17$25

Paid to pharmacies, not to this prescriber.

Other hand surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →